References
- Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope 2008;118:1236–47.
- Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010;401:70–9.
- Schiffman M, Castle PE. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 2003;127:930–4.
- Silver RD, Rimell FL, Adams GL, Derkay CS, Hester R. Diagnosis and management of pulmonary metastasis from recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 2003;129:622–9.
- Srivastava S, Gupta S, Roy JK. High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar Pradesh, India: a population-based study. J Biosci 2012;37:63–72.
- Forslund O, et al. Viral load and mRNA expression of HPV type 6 among recurrent respiratory papillomatosis. 2015. Clinical Microbiology Laboratory at Skåne University Hospital in Malmö. Unpublished data.
- Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356:1928–43.
- D’Souza G, Dempsey A. The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med 2011;53:S5–S11.
- Steinau M, Saraiya M, Goodman MT, Peters ES, Watson M, Cleveland JL, et al. Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis 2014;20:822–8.
- Mahmud SM, Kliewer EV, Lambert P, Bozat-Emre S, Demers AA. Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba, Canada. J Clin Oncol 2014;32:438–43.
- Syrjanen S. Current concepts on human papillomavirus infections in children. APMIS 2010;118:494–509.
- Shah KV. A case for immunization of human papillomavirus (HPV) 6/11-infected pregnant women with the quadrivalent HPV vaccine to prevent juvenile-onset laryngeal papilloma. J Infect Dis 2014;209:1307–9.
- Lizano M, Ibieta-Zarco B, Ponce-de-Leon-Rosales S. The role of head and neck cancer anatomic subsites when evaluating HPV prevalence - reply. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;115:417.
- Derkay CS, Volsky PG, Rosen CA, Pransky SM, McMurray JS, Chadha NK, et al. Current use of intralesional cidofovir for recurrent respiratory papillomatosis. Laryngoscope 2013;123:705–12.
- Derkay CS, Hester RP, Burke B, Carron J, Lawson L. Analysis of a staging assessment system for prediction of surgical interval in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2004;68:1493–8.
- Komlos KF, Kocjan BJ, Kosorok P, Luzar B, Meglic L, Potocnik M, et al. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens. J Med Virol 2012;84:1233–41.
- Loizou C, Laurell G, Lindquist D, Olofsson K. Voice and quality of life in patients with recurrent respiratory papillomatosis in a northern Sweden cohort. Acta Otolaryngol 2014;134:401–6.
- Hirai R, Makiyama K, Higuti Y, Ikeda A, Miura M, Hasegawa H, et al. Pharyngeal squamous cell papilloma in adult Japanese: comparison with laryngeal papilloma in clinical manifestations and HPV infection. Eur Arch Otorhinolaryngol 2012;269:2271–6.
- Hammarstedt L, Lu Y, Marklund L, Dalianis T, Munck-Wikland E, Ye W. Differential survival trends for patients with tonsillar, base of tongue and tongue cancer in Sweden. Oral Oncol 2011;47:636–41.
- Koskinen WJ, Brondbo K, Mellin Dahlstrand H, Luostarinen T, Hakulinen T, Leivo I, et al. Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. J Cancer Res Clin Oncol 2007;133:673–8.
- Cancer incidence in Sweden 2011. The National Board of Health and Welfare, The Swedish Cancer Registry, Stockholm, 2011.